105 related articles for article (PubMed ID: 1581227)
1. Malignant diseases after allogeneic bone marrow transplantation: the case for assessment of risk factors.
Socié G; Kolb HJ; Ljungman P
Br J Haematol; 1992 Apr; 80(4):427-30. PubMed ID: 1581227
[No Abstract] [Full Text] [Related]
2. Malignant diseases after allogeneic bone marrow transplantation: an updated overview.
Socié G; Henry-Amar M; Devergie A; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S75-7. PubMed ID: 8177721
[TBL] [Abstract][Full Text] [Related]
3. Malignant diseases after bone marrow transplantation: the case for tumor banking and continued reporting to registries. EBMT Late-Effects Working Party.
Socié G; Kolb HJ
Bone Marrow Transplant; 1995 Oct; 16(4):493-5. PubMed ID: 8528162
[No Abstract] [Full Text] [Related]
4. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
[TBL] [Abstract][Full Text] [Related]
5. Tumors in allograft recipients.
Penn I
N Engl J Med; 1979 Aug; 301(7):385. PubMed ID: 379644
[No Abstract] [Full Text] [Related]
6. [Donor-cell-derived acute leukemias after allogeneic bone marrow transplantation].
Gopcsa L; Pálóczi K
Orv Hetil; 2003 May; 144(19):907-16. PubMed ID: 12809067
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma of the buccal mucosa in a young adult with history of allogeneic bone marrow transplantation for childhood acute leukemia.
Tomihara K; Dehari H; Yamaguchi A; Abe M; Miyazaki A; Nakamori K; Hareyama M; Hiratsuka H
Head Neck; 2009 Apr; 31(4):565-8. PubMed ID: 18972418
[TBL] [Abstract][Full Text] [Related]
8. Current status of allogeneic bone marrow transplantation in leukemia: a report from the International Bone Marrow Transplant Registry.
Bortin MM; Gale RP
Clin Transpl; 1987; ():127-40. PubMed ID: 3154378
[TBL] [Abstract][Full Text] [Related]
9. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.
Witherspoon RP; Fisher LD; Schoch G; Martin P; Sullivan KM; Sanders J; Deeg HJ; Doney K; Thomas D; Storb R
N Engl J Med; 1989 Sep; 321(12):784-9. PubMed ID: 2671734
[TBL] [Abstract][Full Text] [Related]
10. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation.
Gondek LP; Zheng G; Ghiaur G; DeZern AE; Matsui W; Yegnasubramanian S; Lin MT; Levis M; Eshleman JR; Varadhan R; Tucker N; Jones R; Gocke CD
Leukemia; 2016 Sep; 30(9):1916-1920. PubMed ID: 26975880
[No Abstract] [Full Text] [Related]
11. Neoplasms and transplantation - trading swords for plowshares.
Schenkein DP; Schwartz RS
N Engl J Med; 1997 Mar; 336(13):949-50. PubMed ID: 9070477
[No Abstract] [Full Text] [Related]
12. Myelodysplasia and acute leukemia after autologous bone marrow transplantation.
Armitage JO
J Clin Oncol; 2000 Mar; 18(5):945-6. PubMed ID: 10694542
[No Abstract] [Full Text] [Related]
13. Esophageal squamous cell carcinoma developed 11 years after allogeneic bone marrow transplantation for acute lymphatic leukemia.
Miyawaki Y; Imoto I; Tokairin Y; Kawada K; Nakajima Y; Nishikage T; Nagai K; Kajiwara M; Inazawa J; Kawano T
Jpn J Clin Oncol; 2013 Jan; 43(1):69-73. PubMed ID: 23225908
[TBL] [Abstract][Full Text] [Related]
14. Current status of bone marrow transplantation.
Bortin MM; Horowitz MM
Clin Transpl; 1989; ():93-104. PubMed ID: 2487630
[TBL] [Abstract][Full Text] [Related]
15. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
Kolb HJ; Socié G; Duell T; Van Lint MT; Tichelli A; Apperley JF; Nekolla E; Ljungman P; Jacobsen N; van Weel M; Wick R; Weiss M; Prentice HG
Ann Intern Med; 1999 Nov; 131(10):738-44. PubMed ID: 10577296
[TBL] [Abstract][Full Text] [Related]
16. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation.
Gratwohl A
Haematologica; 2005 Feb; 90(2):151. PubMed ID: 15713580
[No Abstract] [Full Text] [Related]
18. Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma.
Nysom K; Holm K; Hesse B; Ulrik CS; Jacobsen N; Bisgaard H; Hertz H
Arch Dis Child; 1996 May; 74(5):432-6. PubMed ID: 8669960
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic transplantation in malignant lymphoma].
Stötzer OJ; Schleuning M; Ledderose G; Hiddemann W; Kolb HJ
Dtsch Med Wochenschr; 2001 Sep; 126(39):1062-9. PubMed ID: 11602913
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
Yee GC; McGuire TR
Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
